跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REMUVA 250 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
REMUVA 250 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Approved
STANDARD
REMUVA 250 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Aristo Pharma Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 22, 2022
Approval ID
e6254ad24f2bd864
Company
Aristo Pharma Gmbh
Type
Standard
Approval Details
Approval Id
e6254ad24f2bd864
Drug Cima Aemps Name
REMUVA 250 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Register Number
88304
Holder Company Name
Aristo Pharma Gmbh
Marketing Company Name
Aristo Pharma Iberia S.L.
Holder Company Detail Path
/organization/aristo-pharma-gmbh
Authorization Date
2022-11-22
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
250 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Estupefacientes
Commercialized
No
Company Name
Aristo Pharma Gmbh
Company Detail Path
/organization/aristo-pharma-gmbh
Company Information
Pharmaceutical Company Name
Aristo Pharma GmbH
Country Name
Germany
Website
http://www.aristo-pharma.de
Active Ingredients
TAPENTADOL FOSFATO
382,84 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 22, 2022
Approval ID
e6254ad24f2bd864
Type
Standard
Back to CIMA-AEMPS Approvals